| (210) | Number of the EPO application | 19733151 |
| (220) | Filing date of the EPO application | 2019.06.11 |
| (80) | EPO patent specification publication (B) | EPB nr. 22/2023, 2023.05.31 |
| (110) | EPO patent number | 3806955 |
| (11) | Number of the document | MD 3806955 T3 |
| (21) | Number of the application | e 2021 0363 |
| (71) | Name(s) of applicant(s), code of the country | PFIZER INC., US; |
| (72) | Name(s) of inventor(s), code of the country | ASPNES Gary Erik, DE;
BAGLEY Scott W., US;
CURTO John M., US;
EDMONDS David James, US;
FLANAGAN Mark E., US;
FUTATSUGI Kentaro, US;
GRIFFITH David A., US;
HUARD Kim, US;
LIAN Yajing, US;
LIMBERAKIS Chris, US;
LONDREGAN Allyn T., US;
MATHIOWETZ Alan M., US;
PIOTROWSKI David W., US;
RUGGERI Roger B., US; |
| (73) | Name(s) of owner(s), code of the country | PFIZER INC., US; |
| (54) | Title of the invention | GLP-1 receptor agonists and uses thereof |
| (13) | Kind-of-document code | T3 |
| (51) | International Patent Classification | A61P 3/10 (2006.01.01); C07D 413/14 (2006.01.01); C07D 405/12 (2006.01.01); A61K 31/496 (2006.01.01); C07D 405/14 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.05.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.09.30 |
| (30) | Priority | 201862684696 P, 2018.06.13, US; 201962846944 P, 2019.05.13, US; 201962851206 P, 2019.05.22, US |
| (74) | Patent attorney | (Procedură) LAZICOV Tatiana, str. A. Pușkin nr. 33, ap. 73, MD-2012, Chișinau, Republica Moldova |
| (86) | International application | PCT/IB2019/054867, 2019.06.11 |
| (87) | International publication | WO 2019/239319, 2019.12.19 |